Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
Stock
PRAX
PRAX News & Events
-
Add to Watchlist
Trade PRAX
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
PRAX News
Praxis Precision Medicines Set to Announce Q4 Earnings
5h ago
seekingalpha
Cormorant Increases MoonLake Stake Above 6%
17h ago
stocktwits
Affinity Asset Advisors Acquires New Stake in Praxis Precision Medicines
4d ago
Fool
Affinity Asset Advisors Initiates Position in PRAX with 185,000 Shares
4d ago
NASDAQ.COM
Soleus Capital Increases Stake in Celcuity
5d ago
Fool
Praxis Precision Medicines to Report Q4 and Full Year 2025 Financial Results
Feb 09 2026
Yahoo Finance
Praxis Precision Medicines Appoints Dr. Orrin Devinsky as Head of Clinical Strategy
Jan 13 2026
Globenewswire
Praxis Grants 434 Restricted Stock Units to Attract New Employees
Jan 09 2026
Globenewswire
Show More News
PRAX Events
No data
PRAX Monitor News
Praxis Precision Medicines to Report Q4 and Full Year 2025 Financial Results
Feb 12 2026
Praxis Precision Medicines Inc rises as it crosses above 5-day SMA
Jan 27 2026
Praxis Precision Medicines falls amid sector rotation
Jan 26 2026
Praxis Precision Medicines Appoints Dr. Orrin Devinsky as Head of Clinical Strategy
Jan 16 2026
Praxis Precision Medicines Appoints Dr. Orrin Devinsky as Head of Clinical Strategy
Jan 14 2026
Praxis Precision Medicines Prices $575M Share Offering
Jan 12 2026
Praxis Precision Medicines raises $575 million through share offering
Jan 07 2026
Praxis Receives FDA Breakthrough Therapy Designation for Ulixacaltamide
Dec 29 2025
Show More Monitor News
PRAX Earnings Analysis
No Data
People Also Watch
